The prospective, observational study involved 321 patients with acute STEMI, without cardiogenic shock, who received 357 Genous stents. The rate of major adverse cardiac events (MACE) was 8.1%
To support its R&D program, LecTec has established relationships with bio-medical companies based in China, Japan, Thailand and the US, to assist the company in developing its antimicrobial
The study consisted of a blinded, randomized clinical trial involving 46 dogs recruited from the public. The animals were randomly assigned to receive either the Oximunol supplement (0.5mg/kg
Prior to HandyLab, Mr. Williams has been president and chief executive officer of Genomic Solutions, an Ann Arbor-based life science instrumentation company. He led Genomic Solutions through a
The reports capture the results of a broad-scale international clinical development program designed to evaluate the efficacy of ulipristal acetate, HRA Pharma’s progesterone receptor modulator, as a method
The phase 3, pivotal trial assessed the safety and RSV hospitalisation in 6,635 preterm infants aged six months or younger at enrollment or children aged 24 months or
In the phase 2 study, 37 patients were treated with Perifosine 150mg daily for six cycles. Over 41% of the patients had three or more lines of prior
For vaccines to be effective, they are to be stored within the temperature range recommended by manufacturers [+2°C to +8°C]. Cool-Tel systems monitor and record the temperature of
Bone has filed an IND submission in September 2009 for a 180 patient, one month phase 2b dose-ranging study using Womac as the primary endpoint for pain. The
The Microcyn Solution for professional use is intended for the irrigation and management via debridement of post-surgical wounds. Available in 500ml and 990ml units with attached pharmasling hangers,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.